[1]Patent:US6319918,2001,B1
[2]Patent:US6169106,2001,A
[1]JournalofMedicinalChemistry,2010,vol.53,p.7287-7295
[2]BioorganicandMedicinalChemistry,2017,vol.25,p.2609-2616
102359-00-2
199328-10-4
153247-93-9
129912-25-0
896160-47-7
1094303-82-8
24779-49-5 | Piperazine, 1,2,5-trimethyl-, (2R,5S)-rel- | AA002PBO | MFCD12755750
2489-89-6 | 4-(2-Naphthyl)-1-butene | AA002POA | MFCD09801378
24973-50-0 | 3-Phenylbenzonitrile | AA002PZG | MFCD00236364
250726-93-3 | 2,3-Dihydrothieno[3,4-b][1,4]dioxin-5-ylboronic acid, pinacol ester | AA002QB4 | MFCD08060541
2516-47-4 | Cyclopropylmethanamine | AA002QME | MFCD12407110
933-95-9 | 2-Amino-2-cyclopentylacetic acid | AA002QVD | MFCD09264351
259793-90-3 | 6-Chloro-3-hydroxypyrazine-2-carboxamide | AA002R6Z | MFCD20702468
260806-90-4 | methyl 3-bromo-2-methoxybenzoate | AA002RIO | MFCD11042778
26145-14-2 | 4-(4-Bromophenyl)thiophene-2-carboxylic acid | AA002RSA | MFCD03407986
261763-02-4 | 3-Chloro-2-fluoro-5-(trifluoromethyl)benzaldehyde | AA002RYZ | MFCD01631510